Elanco market cap is $12.8 b, and annual revenue was $3.27 b in FY 2020

Elanco Gross profit (FY, 2020)1.6 B

Elanco Gross profit margin (FY, 2020), %49.1%

Elanco Net income (FY, 2020)-560.1 M

Elanco Cash, 31-Dec-2020494.7 M

Elanco EV18.4 B

Elanco revenue was $3.27 b in FY, 2020

Elanco revenue breakdown by business segment: 25.7% from CA Disease Prevention, 11.3% from CA Therapeutics, 24.3% from FA Future Protein & Health, 36.2% from FA Ruminants & Swine and 2.6% from Other

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Revenue | 2.9b | 3.1b | 3.1b | 3.3b |

| 6% | 0% | ||

## Cost of goods sold | 1.5b | 1.6b | 1.5b | 1.7b |

## Gross profit | 1.4b | 1.5b | 1.6b | 1.6b |

| 48% | 49% | 52% | 49% |

## R&D expense | 251.7m | 246.6m | 270.1m | |

## General and administrative expense | 779.8m | 735.2m | 760.2m | 996.6m |

## Operating expense total | 1.3b | 1.3b | 1.4b | 996.6m |

## Depreciation and amortization | 197.4m | 197.4m | 200.4m | 359.9m |

## Interest expense | 29.6m | 29.6m | 78.9m | 149.8m |

## Pre tax profit | 114.1m | 114.1m | 78.2m | |

## Income tax expense | 27.6m | 27.6m | 10.3m | (111.9m) |

## Net Income | 86.5m | 86.5m | 67.9m | (560.1m) |

## EPS | 0.3 | 0.3 | 0.2 |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 736.2m | 770.2m | 761.1m | 731.1m | 781.6m | 771.3m | 657.7m | 586.3m | 889.6m |

## Cost of goods sold | 360.0m | 431.5m | 369.8m | 343.8m | 356.0m | 360.4m | 332.7m | 295.9m | 441.8m |

## Gross profit | 376.2m | 338.7m | 391.3m | 387.3m | 425.6m | 410.9m | 325.0m | 290.4m | 447.8m |

| 51% | 44% | 51% | 53% | 54% | 53% | 49% | 50% | 50% |

## R&D expense | 65.2m | 61.4m | 58.9m | 64.1m | 68.8m | 69.9m | 66.8m | 59.4m | 88.1m |

## General and administrative expense | 180.0m | 191.1m | 179.0m | 181.1m | 200.9m | 192.3m | 182.0m | 162.8m | 277.7m |

## Operating expense total | 319.1m | 369.9m | 299.0m | 319.1m | 350.8m | 390.1m | 375.2m | 390.6m | 723.6m |

## Depreciation and amortization | 49.0m | 49.3m | 48.7m | 24.9m | 49.3m | 50.7m | 51.6m | 49.0m | 95.6m |

## Interest expense | 20.8m | 20.7m | 20.8m | 20.7m | 18.7m | 16.5m | 24.8m | 48.1m | |

## Pre tax profit | 44.8m | 50.2m | 78.8m | 44.8m | 50.2m | (12.5m) | (67.8m) | (77.1m) | (209.0m) |

## Income tax expense | 13.3m | 14.3m | 18.6m | 13.3m | 14.3m | (22.5m) | (18.7m) | (23.9m) | (74.0m) |

## Net Income | 31.5m | 35.9m | 60.2m | 31.5m | 35.9m | 10.0m | (49.1m) | (53.2m) | (135.0m) |

## EPS | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | (0.1) | (0.1) | (0.3) |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Cash | 323.4m | 474.8m | 345.1m | 494.7m |

## Accounts Receivable | 567.4m | 651.8m | 816.9m | 871.6m |

## Prepaid Expenses | 136.1m | 113.9m | 87.4m | 256.3m |

## Inventories | 1.1b | 1.0b | 1.1b | 1.6b |

## Current Assets | 2.1b | 2.5b | 2.4b | 3.4b |

## PP&E | 920.3m | 922.4m | 955.3m | 1.3b |

## Goodwill | 3.0b | 3.0b | 3.0b | |

## Total Assets | 8.9b | 9.0b | 9.0b | 17.7b |

## Accounts Payable | 203.8m | 205.2m | 222.6m | |

## Short-term debt | 29.0m | 24.5m | 554.5m | |

## Current Liabilities | 643.1m | 970.7m | 818.5m | 2.1b |

## Long-term debt | 2.4b | 2.3b | 5.6b | |

## Total Debt | 2.5b | 2.4b | 6.1b | |

## Total Liabilities | 1.2b | 3.8b | 3.4b | 9.2b |

## Common Stock | ||||

## Preferred Stock | ||||

## Additional Paid-in Capital | 5.4b | 5.6b | 8.7b | |

## Retained Earnings | 16.4m | 84.3m | (477.2m) | |

## Total Equity | 7.8b | 5.2b | 5.5b | 8.5b |

## Debt to Equity Ratio | 0.5 x | 0.4 x | ||

## Debt to Assets Ratio | 0.3 x | 0.3 x | ||

## Financial Leverage | 1.1 x | 1.7 x | 1.6 x | 2.1 x |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Net Income | (310.7m) | 86.5m | 67.9m | (560.1m) |

## Depreciation and Amortization | 318.4m | 296.0m | 314.5m | 516.9m |

## Accounts Receivable | 48.4m | (122.0m) | (172.4m) | |

## Inventories | (39.0m) | (20.1m) | (33.1m) | (94.7m) |

## Accounts Payable | (8.4m) | 116.1m | (29.2m) | 369.3m |

## Cash From Operating Activities | 173.8m | 487.3m | 224.1m | |

## Purchases of PP&E | (98.6m) | (134.5m) | (140.4m) | (134.6m) |

## Cash From Investing Activities | (964.6m) | (127.0m) | (234.8m) | (4.8b) |

## Long-term Borrowings | (7.5m) | (121.1m) | (951.5m) | |

## Cash From Financing Activities | 847.5m | (35.2m) | (304.8m) | 5.0b |

## Net Change in Cash | 64.6m | 354.1m | (332.4m) | 160.3m |

## Income Taxes Paid | 12.9m |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | 72.7m | 9.9m | 70.1m | 31.5m | 67.4m | 77.4m | (49.1m) | (102.3m) | (237.3m) |

## Depreciation and Amortization | 74.3m | 149.6m | 222.3m | 83.1m | 152.4m | 231.1m | 81.5m | 162.4m | 294.7m |

## Cash From Operating Activities | 47.0m | 183.9m | 347.8m | 5.6m | 58.2m | 97.8m | 4.3m | 163.6m | 51.9m |

## Purchases of PP&E | (31.7m) | (56.5m) | (74.3m) | (28.0m) | (51.8m) | (86.0m) | (12.6m) | (16.2m) | |

## Cash From Investing Activities | (34.4m) | (57.5m) | (78.9m) | (28.5m) | (77.5m) | (160.5m) | (19.6m) | (9.0m) | (4.7b) |

## Long-term Borrowings | (7.5m) | (65.0m) | (115.0m) | (371.4m) | (377.8m) | (684.2m) | |||

## Cash From Financing Activities | (76.5m) | (123.7m) | 327.2m | (339.5m) | (249.8m) | (298.6m) | 896.6m | 903.9m | 5.0b |

## Net Change in Cash | (60.0m) | (2.4m) | 611.5m | (376.9m) | (280.9m) | (357.2m) | 872.0m | 1.1b | 325.5m |

USD | FY, 2017 |
---|---|

## Financial Leverage | 1.1 x |